LP group (n = 78) | LPS group (n = 54) | P value | |
---|---|---|---|
Pathological type (n, %) | 0.9910 | ||
Clear cell | 56 (71.8%) | 38 (70.4%) | 1.0000 |
Granular cell | 14 (17.9%) | 9 (16.7%) | 1.0000 |
Papillary | 2 (2.6%) | 1 (1.9%) | 1.0000 |
Chromophobe | 4 (5.1%) | 3 (5.6%) | 1.0000 |
Others | 4 (5.1%) | 4 (7.4%) | 0.7156 |
Metastatic | 3 (3.8%) | 1 (1.9%) | 0.6443 |
Tumor staging (n, %) | < 0.0001 | ||
pT1a | 4 (6.4%) | 17 (31.5%) | < 0.0001 |
pT1b | 9 (11.5%) | 6 (11.1%) | 1.0000 |
pT2 | 31 (39.7%) | 25 (46.3%) | 0.4784 |
pT3a | 30 (38.5%) | 6 (11.1%) | < 0.0001 |
pT3b | 4 (5.1%) | 0 (0.0%) | 0.1442 |